BRUSSELS (AP) — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...

The European Commission has fined Israeli drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) EUR 462.6M, or around $500M, for trying to ward off competition for its blockbuster multiple sclerosis ...

The FDA on Tuesday approved Novartis’ generic version of Teva Pharmaceutical’s best-selling multiple sclerosis drug, Copaxone, reports Reuters. Here are three things to know. 1. Glatopa, manufactured ...

Read full article: Lenovo 2-in-1 Chromebook for $79.99? Here’s why it’s worth it 1-Year Sam's Club Membership with Auto-Renew BRUSSELS – The European Commission said Thursday it has fined Israeli ...

Read full article: Veteran, civil rights groups want President Biden to give WWI veteran the Medal of Honor Young Men's Leadership Academy celebrating 10 years of success. Here's how to get fabulous ...

Read full article: Airbnb announces 3-year partnership with FIFA ahead of World Cup 2026 in Houston Read full article: Swap cloud storage fees storage fees for this $70 1TB flash drive! Seido™ ...

BRUSSELS — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. BRUSSELS (AP) — The European Commission said ...